Mark Bagnall

Mark N.
K.
Bagnall is the founder of Naia Rare Diseases LLC, founded in 2014, where the title held is Chief Operating Officer.
Current jobs include Chief Executive Officer at Phenomix Sciences LLC since 2021, Chief Executive Officer at Phenomix Sciences, Inc. since 2021, Chairman at XCR Diagnostics, Inc., and Director at Ativa Medical Corp.
since 2014.
Former jobs include Director at ThermoGenesis Holdings, Inc. in 2016, Director at Forticell Bioscience, Inc. from 2007 to 2008, Independent Director at VIA Pharmaceuticals, Inc. from 2007 to 2011, President & Director at GENTURAdx USA, Inc. in 2011, Principal at Somatix Therapy Corp., Principal at Progenitor, Inc., Chief Financial Officer & Executive Vice President at Mast Therapeutics, Inc. in 2009, SVP, Chief Operating & Financial Officer at CymaBay Therapeutics, Inc. from 2000 to 2007, and Principal at Metrika, Inc. Education includes undergraduate studies at the University of California, Berkeley.